Media Partners

Biotechnology Focus web site and magazine are an essential source of news on everything from business and regulation to research and development in the Canadian life sciences industry. With the driving goal of furthering the understanding of the Canadian life sciences industry, Biotechnology Focus offers a medium where principal investigators, entrepreneurs and life sciences executives can find advice, insights, and inspiration on how to best run and grow their businesses. As the leading forum for the industry in Canada, we can help you connect with the life sciences market through a full suite of communications and marketing products. We offer both print and online media services, including blogs, newsletters, social media outreach and events. Visit http://biotechnologyfocus.ca to learn more.

PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Montréal InVivo is an economic development organization dedicated to the creation of a business environment that fosters innovation and growth of companies and organizations in the life sciences and health technologies (LSHT) sector. Montréal InVivo provides strategic leverage and initiates and coordinates key actions to collectively seize development opportunities facing the cluster. Montreal InVivo’s cluster represents the life sciences and health technologies (LSHT) of Metropolitan Montreal. This cluster is composed  of nearly 620 organizations, including more than 150 research centers and 80 subsidiaries of world-class companies and 41,000 people working in the sector. This cluster generating great ideas includes four universities and ranks first in Canada for the number of research centers. The cluster assumes a leadership role in rallying players around common goals aimed at ensuring the growth and competitiveness of LSHT in Greater Montréal and throughout Québec.

Biotechgate is a global life science data source covering the biotech, pharma and medtech industries. There are currently over 49,000 company profiles available with product pipelines, technologies, in/out licensing opportunities, management details and financial rounds information. Biotechgate is the ideal solution for those looking for partners, clients or funding.

BIOQuébec, Québec’s biotechnology and life sciences network, is committed to supporting the growth of Québec’s biotechnology and life sciences industry to position Québec, on an international scale, as an undeniable key player in the biotechnology and life sciences field. Founded in 1991, this NPC focuses on providing governmental representation, business development opportunities, and partnerships to allow its members to reduce their operating costs.  Its members are companies and organizations which operate at every level of the biotechnology and life sciences innovation sector and are active in researching, developing, and marketing new tests, drugs, and other life sciences-related products and services

Vantage BioTrials Inc. is a privately-held, CRO that provides Phase I-IV clinical trial management services to international pharmaceutical, biotechnology, generic pharmaceutical and medical device companies within North America and Europe. We are one of the only Canadian CROs named as an “Emerging Pharma Leader” by Pharmaceutical Executive Magazine for its lean management style and effectiveness in realizing project goals. Experts in implementing Risk-Based Management through the use of Quality by Design (QbD) methodologies, we accelerate the conduct of a study and reduce overall risk. As a result this ensures that your trial is performed correctly, the first time! Feel free to download Vantage BioTrials’ corporate presentation (PDF) which further explains our background and business model and highlights our expertise, or visit www.vantagebiotrials.com for more information.